Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metarka 50mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Arkamed Pharmaa

Salt Composition

Metoprolol Succinate (50mg)

Overview Metarka 50mg Tablet ER

CardioBeta 50mg Extended-Release Tablets are classified as beta-adrenergic blockers. This medication treats hypertension (high blood pressure), angina pectoris (chest pain due to heart conditions), and cardiac arrhythmias (irregular heartbeats). It also serves as prophylaxis against migraines, future myocardial infarctions (heart attacks), and cerebrovascular accidents (strokes). CardioBeta 50mg ER may be administered independently or in conjunction with other therapies. Dosage and frequency are determined by the indication and disease severity. It can be ingested with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic benefit may take several weeks to manifest, and long-term use is often necessary. Continued use is vital, even with symptom improvement; discontinuation can exacerbate underlying conditions. Common, generally mild and transient, adverse effects include fatigue, cephalalgia (headache), depressive symptoms, diarrhea, skin rash, bradycardia (slow heart rate), lightheadedness, and nausea. Less frequently, dyspnea (shortness of breath) or hypotension (low blood pressure) may occur. Gradual dose escalation minimizes adverse event risk. Report persistent or bothersome side effects to your physician. Prior to initiating therapy, disclose any hepatic (liver) impairment. CardioBeta 50mg ER is contraindicated in patients with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating individuals require medical consultation before commencing treatment. Individual suitability should be confirmed by a healthcare professional, and regular blood pressure monitoring is recommended to assess treatment effectiveness. Alcohol consumption should be avoided due to the potential for exacerbated side effects.

Uses of Metarka 50mg Tablet ER

Managing angina pectoris (chest pain from heart disease) | Addressing cardiac arrhythmias | Reducing heart attack risk | Hypertension (high blood pressure) management | Migraine prophylaxis

Major Benefits of Metarka 50mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 50mg Metarka Extended-Release tablet whole; do not crush, chew, or break it. This medication can be taken with or without food, but consistency in timing is recommended. High-fat foods, including olive oil, nuts (like Brazil nuts), dark chocolate, butter, and meat, should be avoided when taking Metarka 50mg ER tablets.

Common Side effects of Metarka 50mg Tablet ER:

  • Tiredness
  • Dizziness
  • Depression
  • Breathlessness
  • Headache
  • Slow heart rate
  • Nausea
  • Rash
  • Diarrhea
  • Hypotension (low blood pressure)

How to use Metarka 50mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Metarka 50mg Extended-Release tablet whole; do not crush, chew, or break it. This medication can be taken with or without food, but consistency in timing is recommended. Minimize consumption of high-fat foods like olive oil, nuts (including Brazil nuts), dark chocolate, butter, and meat while taking Metarka 50mg Tablet ER.

How Metarka 50mg Tablet ER works:

Cardio-selective extended-release Metarka 50mg tablets reduce cardiac workload. This is achieved by decreasing heart rate and enhancing the efficiency of blood circulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Metarka 50mg Extended-Release Tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Metarka 50mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Metarka 50mg tablets are likely safe for breastfeeding mothers. Available evidence from humans indicates minimal infant risk associated with the medication.

DrivingDrivingUNSAFE

Extended-release Metarka 50mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Metarka 50mg tablets are considered safe for individuals with kidney impairment. No alteration of the Metarka 50mg ER tablet dosage is necessary.

LiverLiverCAUTION

Patients with liver impairment should use Metarka 50mg Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Metarka 50mg Tablet ER :

Should you forget to take a Metarka 50mg Extended-Release Tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metarka 50mg Tablet ER

LabelValue
Type of Compound Ethanol and phenolic compounds
Potential for Dependence None.
Type of Medication HEART

FAQs on Metarka 50mg Tablet ER

Individual responses to Metarka 50mg Extended-Release Tablets vary. Onset typically occurs within 15 minutes, although it may take up to two hours in some individuals. The therapeutic effect is gradual, with peak efficacy generally achieved within one week. Absence of immediate noticeable effects shouldn't cause alarm; sustained use is necessary to realize the drug's full benefits.
Extended-release Metarka 50mg tablets generally pose minimal risk when administered according to a physician's instructions. However, abrupt cessation can trigger hazardous consequences. Sudden discontinuation may sharply elevate heart rate and impair cardiac function, potentially endangering individuals with heart failure and even causing a heart attack in some cases. Therefore, discontinue this medication only under medical supervision and adhere to the prescribed treatment regimen.
Metarka 50mg Extended-Release tablets are classified as beta-blockers. While individual responses differ, some users report sleep disturbances, such as altered sleep patterns. Conversely, others experiencing elevated heart rate and anxiety may find their sleep improved due to the medication's calming effects on the cardiovascular and nervous systems. Consult your physician regarding any sleep-related issues.
Refrain from alcohol consumption following administration of a 50mg extended-release Metarka tablet. Alcohol can potentiate the hypotensive effects of this medication, potentially causing dangerously low blood pressure.
Metarka 50mg Tablet ER
47
MRP 55
14% off